WPC &; 6MWˁ%R$$p?|n6` U{?t 7bV:ZJ= qw Xw_l%ilUvlΞ}ӿiE( lYbhK7SO]zCb fځ!z 1b"CytΆ7wq\\\PǽͩB_i u ؋lK9@*|?^]|eO8j%yۧvn\ZZLHhb!-'9{56!}i숭w%B WqKm^MzvFjysh@PCc W)na0YzN&o_th /K-%7@2U]#U N %% 0:+ fe ag ^ { w 4   m   S 0N g - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - B HP LaserJet 4Si,,,,,,0(9 Z6Times New Roman RegularX($USUS.,ԌdTABLE AӑE)L dD)N3|xULevel 1Level 2Level 3Level 4Level 5Level 1Level 2Level 3Level 4Level 5Level 1Level 2Level 3Level 4Level 5(O$ԄLevel 1Level 2Level 3Level 4Level 5Level 1Level 2Level 3Level 4Level 5 d !USUS.,  _X&%XX@& #XX%&K#$XX_ICD_ԄO3    CodingExercise  @@= = LymphomaandLeukemiaHistologyCoding#XX$#&%XX  < *\ddd Xdd Xdd X(#(#,7dd ,dd ,9dd +  $   $DiagnosticStatement ' d 'Histology/Behavior ' d 'Grade*  d  Ѐ1._ANLL_Ԁ(acutenonlymphocyticleukemia)               Ѐ2.Bcelllymphoma   <     <     <  Ѐ3._AML_Ԁt(8;21)(q22;q22)  X    X    X  Ѐ4.M2acutemyelocyticleukemia            Ѐ5._Mucosal_Ԁassociatedlymphoidtissue(MALT)lymphoma  0    0    0  Ѐ6.AnaplasticlargeBcelllymphoma         Ѐ7._Intravascular_ԀBcelllymphoma  X   X   X Ѐ8.Diffuse_histiocytic_Ԁlymphoma  t   t    t! Ѐ9.TcellrichlargeBcelllymphoma  0"   0#   0$ 10._Centroblastic_Ԁlymphoma  L%   L&   L' 11.NodularlymphocytepredominantHodgkinsdisease  (   )   * 12.DiffuselymphocytepredominanceHodgkinsdisease  $t+   $t,   $t- 13.Hodgkinlymphoma,classiclymphocyterich  .   /   0 14.AdultTcelllymphoma  L1   L2   L3 15.AdultTcellleukemia  h 4   h 5   h 6 16._AML_Ԁdueto_Etoposide_Ԁtreatmentfortesticularcancer  !$7   !$8   !$9 17.Bcellchroniclymphocyticleukemia/smalllymphocytic @#: Ѐlymphomadiagnosedincervicallymphnodes  $h;   @#<  @#=  #XX%&#&%XX *SixthDigitCodefor_Immunophenotype_ԀDesignationforLymphomasand_Leukemias_:  &H"? 9% ,XX h XX95Tcell0  6Bcell0 (#(#0 (# (#7Nullcell0 (# (#8_NK_Ԁcell p   9Celltypenotdetermined,(#A(#(#     PreB0 0 (# (#NonTnonBNaturalKillercell0 (# (#notstated,notapplicable)$B(#(#     Bprecursor  h  X*%C #XX%& #= X ,XX h X =